VRTX — Vertex Pharmaceuticals Inc
In 2026 Q2, 8 of the 140 tracked hedge funds reported a position in Vertex Pharmaceuticals Inc (VRTX), worth $263.82M combined. Over the quarter 2 opened or added, 7 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $158.96M | 0.22% | -24.1% |
| VanEck | $71.47M | 0.04% | -1.5% |
| Quadrature | $23.32M | 0.20% | NEW |
| Ardsley | $7.45M | 0.81% | NEW |
| MWA | $1.81M | 0.82% | -12.1% |
| KRS | $780.86K | 0.36% | NO CHANGE |
| Pingora | $32.29K | 0.02% | NO CHANGE |
| Barnes Dennig | $1.49K | 0.00% | NO CHANGE |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.